These four choices could make any $14,000 investment a strong one, especially with solid dividends that will stand the test of time.
Verastem (NASDAQ:VSTM – Get Free Report)‘s stock had its “buy” rating restated by analysts at HC Wainwright in a research report issued to clients and investors on Friday,Benzinga reports. They currently have a $18.00 target price on the biopharmaceutical company’s stock. HC Wainwright’s target price
Groww Shares Gain 22% In One Month! What's Leading The Rally? Read Full Article →
Byrna Technologies (NASDAQ:BYRN – Get Free Report) had its price objective dropped by investment analysts at B. Riley Financial from $31.00 to $21.00 in a report released on Friday,Benzinga reports. The firm presently has a “buy” rating on the stock. B. Riley Financial’s price objective would
Global-e Online Ltd. (NASDAQ:GLBE – Get Free Report) COO Shahar Tamari sold 4,007 shares of the firm’s stock in a transaction dated Wednesday, April 8th. The shares were sold at an average price of $32.26, for a total value of $129,265.82. Following the sale, the
